Prophase Labs Inc (PRPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 19,303 | 21,824 | 24,200 | 29,092 | 47,531 |
| Cost of Goods | 8,783 | 10,540 | 12,227 | 10,372 | 18,854 |
| Gross Profit | 10,520 | 11,284 | 11,973 | 18,720 | 28,677 |
| Operating Expenses | 10,428 | 16,915 | 10,247 | 8,505 | 13,385 |
| Operating Income | 875 | -5,091 | 1,953 | 10,587 | 16,146 |
| Interest Expense | 215 | 129 | 201 | 201 | 233 |
| Other Income | -96 | 30 | 25 | 25 | -3 |
| Pre-tax Income | 564 | -5,190 | 1,777 | 10,411 | 15,910 |
| Income Tax | 14 | -2,745 | 809 | 2,965 | 3,416 |
| Net Income Continuous | 550 | -2,445 | 968 | 7,446 | 12,494 |
| Net Income | $550 | $-2,445 | $968 | $7,446 | $12,494 |
| EPS Basic Total Ops | 0.30 | -1.80 | 0.60 | 4.80 | 8.10 |
| EPS Basic Continuous Ops | 0.33 | -1.81 | 0.61 | 4.78 | 8.07 |
| EPS Diluted Total Ops | 0.30 | -1.20 | 0.60 | 4.00 | 6.80 |
| EPS Diluted Continuous Ops | 0.30 | -1.11 | 0.48 | 3.86 | 6.67 |
| EBITDA(a) | $2,272 | $-4,076 | $3,317 | $11,940 | $17,479 |